Application 089903
- Type
- ANDA
- Sponsor
- WEST-WARD PHARMS INT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | INJECTABLE;INJECTION | EQ 5MG BASE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A089903-001 | PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE / INJECTION | AP | 1989-08-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A089903-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A089903-001 | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE / INJECTION | AP | 1989-08-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A089903-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prochlorperazine Edisylate | PROCHLORPERAZINE EDISYLATE | Hikma Pharmaceuticals USA Inc. | baf59816-7577-4652-b065-fb6de9e54569 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | 089903 ANDA089903 0641-6135 |
| Prochlorperazine Edisylate | PROCHLORPERAZINE EDISYLATE | Civica, Inc. | e3e0c6c5-6b92-40e0-a926-29c64846be93 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | 089903 ANDA089903 72572-580 |
| PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | HF Acquisition Co LLC, DBA HealthFirst | e181c18d-32a8-587e-e053-2995a90acc5b | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 089903 ANDA089903 51662-1558 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0641-0491 | Prochlorperazine Edisylate | Prochlorperazine Edisylate | Baxter Healthcare Corporation | ANDA | Current |
| 0641-6135 | Prochlorperazine Edisylate | Prochlorperazine Edisylate | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0641-6135 | Prochlorperazine Edisylate | Prochlorperazine Edisylate | West-Ward Pharmaceuticals Corp. | ANDA | Current |
| 51662-1558 | PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 72572-580 | Prochlorperazine Edisylate | Prochlorperazine Edisylate | Civica, Inc. | ANDA | Current |